Funder
Agence Nationale de la Recherche
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Calzà L, Beltrami D, Gagliardi G, Ghidoni E, Marcello N, Rossini-Favretti R, Tamburini F (2015) Should we screen for cognitive decline and dementia? Maturitas 82:28–35
2. Carrillo MC, Brashear HR, Logovinsky V, Ryan JM, Feldman HH, Siemers ER, Abushakra S, Hartley DM, Petersen RC, Khachaturian AS, Sperling RA (2013) Can we prevent Alzheimer’s disease? Secondary “prevention” trials in Alzheimer’s disease. Alzheimers Dement 9:123-131.e121
3. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) Cadasil. Lancet Neurol 8:643–653
4. Chabriat H, Joutel A, Tournier-Lasserve E, Bousser MG (2020) CADASIL: yesterday, today, tomorrow. Eur J Neurol Off J Eur Fed Neurol Soc 27:1588–1595
5. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X et al (1995) Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 346:934–939